[1] 中华医学会肝病分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2015更新版).中华肝脏病杂志,2015,23: 888-905.
[2] Li Z, Xue J, Chen P, et al.Prevalence of nonalcoholic fatty liver disease in mainland of China: a meta-analysis of published studies.J Gastroenterol Hepatol,2014,29:42-51.
[3] Joo EJ,Chang Y,Yeom JS,et al. Hepatitis B virus infection and decreased risk of non-alcoholic fatty liver disease: a cohort study.Hepatology,2017,65:828-835.
[4] 刘波,董静,张骏飞,等.HBeAg阳性与阴性慢性乙型肝炎合并脂肪肝患者临床和病理学特征分析.实用肝脏病杂志,2012,15: 397-399.
[5] Wu YL,Peng XE,Zhu YB,et al.Hepatitis B virus X protein induces hepaticsteatosis by enhancing the expression of Liver fatty acid binding protein.J Virol,2015,90: 1729-1740.
[6] Bril F,Lomonaco R,Orsak B,et al.Relationship between disease severity,hyperinsulinemia,and impaired insulin clearance in patients with nonalcoholic steatohepatitis. Hepatology,2014,59: 2178-2187.
[7] 乔月芹,李俊英,匡湧,等.慢性乙型肝炎患者肝纤维化的代谢影响因素分析.中华医院感染学杂志,2016,26: 3889-3891.
[8] Polkey MI, Spruit MA, Edwards LD, et al. Six-minutewalk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalization.Am J Respir Crit Care Med, 2013,187: 382-386.
[9] Izquierdo-Alonso JL, Rodriguez-Gonzá JM, Lucas-Ramosp DE, et al. Prevalence and characteristics of three clinical phenotypes of chronic obstructive pulmonary disease(COPD).Respir Med,2013,107: 724-731.
[10] Goh GB,McCullough AJ.Natural history of nonalcoholic fatty liver disease. Dig Dis Sci,20l6,61: 1226-1233.
[11] Hourigan SK,Abrams S,Yates K,et al.Relation between vitamin D status and nonalcoholic fatty liver disease in children.J Pediatr Gastroenterol Nutr,2015,60: 396-404.
[12] Nelson JE,Roth CL,Wilson LA, et al.Vitamin D deficiency is associated with increased risk of nonalcoholic steatohepatitis in adults with nonalcoholic fatty liver disease: possible role forMAPK and NF-kB? Am J Gastroenterol,2016,111: 852-863.
[13] 张志侨,王功遂,康凯夫,等.基于216对配对病例研究慢性乙型肝炎患者肝脂肪变性的临床和病理特征.中华传染病杂志,2016,34: 146-150.
[14] 陈林均.CHB患者与CHB合并NAFLD患者临床特征对比研究.医疗装备, 2015,8:87-88.
[15] Brorson S,Olsen BS,Frich LH,et al.Surgeons agree more on treatment recommendations than on classification of proximal humeral fractures.BMC Musculoskelet Disord,2012,13:114.
[16] Sporea I, Jurchis A, Sirli R,et al.Can transient elastography be a reliable method forassessing liver fibrosis in non alcoholic steatohepatitis (NASH)? Med Ultrason,2013,15: 106-110.
[17] Romero-Gomez M,Zelber-Sagi S,Trenell M.Treatment of NAFLD with diet, physical activity and exercise.J Hepatol,2017,67: 829-846.
[18] Metrakos P,Nilsson T.Non-alcoholic fatty liver disease-a chronic disease of the 21st?century.J Biomed Res,2017 May 26.
[19] 刘素芬,武博荣,刘振中,等.抗病毒治疗慢性乙型肝炎合并非酒精性脂肪肝疗效观察.现代中西医结合杂志,2015,24: 1980-1982.
[20] Zhao L,Zhang C,Luo X, et al. CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis.J Hepatol, 2018, DOI:https://doi.org/10.1016/j.jhep.2018.04.006. |
